Welcome to HeidelbergCement Group
- HeidelbergCement to sell its calcium silicate unit business
- HeidelbergCement and EMBL explore solutions in CO2 reduction
- HeidelbergCement sells half of its Georgian business
15 December 2017
HeidelbergCement announces that it has signed an agreement with H+H International A/S and its subsidiary H+H Deutschland GmbH to sell its German and Swiss calcium silicate unit business (“HDKS”). The enterprise value of the transaction amounts to about € 110 million. HeidelbergCement expects the transaction to close in the first quarter of 2018. “HDKS has a strong market position in the North-East and South-West of Germany as well as in Switzerland, but the focus of its product portfolio on calcium silicate units is outside the core businesses of HeidelbergCement,” said Dr. Bernd Scheifele,...
20 November 2017
HeidelbergCement and EMBL have signed an agreement on a three-year collaboration to exchange scientific and technical knowledge. A new Memorandum of Understanding co-signed by EMBL and HeidelbergCement aims to encourage beneficial knowledge exchange in areas related to CO2 emission reduction, avoidance and recovery, as well as driving innovation. “We are delighted to be partnering with EMBL, one of the world’s leading research institutions for molecular biology, to jointly explore innovative approaches to fight climate change,” explains Dr. Bernd Scheifele, Chairman of the Managing Board of...
10 November 2017
Today, HeidelbergCement announced that it has sold 50% of the voting rights in its Georgian business to Cement Invest, an investment company jointly managed and owned by the Georgian Co-Investment Fund (“GCF”) and Hunnewell Partners (“Hunnewell”). HeidelbergCement and Cement Invest will jointly control the resulting joint venture. The transaction will contribute in total about € 115 million to the future reduction of net debt of HeidelbergCement. “The partnership will enable our new Georgian joint venture to benefit from GCF’s and Hunnewell’s project experience in Georgia,” explains Dr. Bernd...